Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:438402.
doi: 10.1155/2015/438402. Epub 2015 Mar 23.

Ocular complications of inflammatory bowel disease

Affiliations
Review

Ocular complications of inflammatory bowel disease

Rana Mady et al. ScientificWorldJournal. 2015.

Abstract

Though inflammatory bowel disease (IBD) has a specific predilection for the intestinal tract, it is a systemic inflammatory disorder affecting multiple organs, including the eye. Ocular complications directly related to IBD are categorized as primary and secondary. Primary complications are usually temporally associated with IBD exacerbations and tend to resolve with systemic treatment of the intestinal inflammation. These include keratopathy, episcleritis, and scleritis. Secondary complications arise from primary complications. Examples include cataract formation due to treatment with corticosteroids, scleromalacia due to scleritis, and dry eye due to hypovitaminosis A following gut resection. Some ocular manifestations of IBD can lead to significant visual morbidity and temporally associated complications can also be a herald of disease control. Furthermore, ocular manifestations of IBD can occasionally manifest before the usual intestinal manifestations, leading to an earlier diagnosis. Thus, it is important to understand the clinical presentation of possible ocular manifestations in order to initiate appropriate treatment and to help prevent significant visual morbidity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Fenoglio-Preiser C. M., Noffsinger A. E., Stemmermann G. N., Lantz P. E., Isaacson P. G. Gastrointestinal Pathology: An Atlas and Text. 3rd. Philadelphia, Pa, USA: Lippincott Williams & Wilkins; 2008.
    1. Mintz R., Feller E., Bahr R. L., Shah S. A. Ocular manifestations of inflammatory bowel disease. Inflammatory Bowel Diseases. 2004;10(2):135–139. doi: 10.1097/00054725-200403000-00012. - DOI - PubMed
    1. Salmon J. F., Wright J. P., Murray A. D. N. Ocular inflammation in Crohn's disease. Ophthalmology. 1991;98(4):480–484. doi: 10.1016/S0161-6420(91)32268-1. - DOI - PubMed
    1. Krachmer J. H., Mannis M. J., Holland E. J. Cornea. 3rd. Elsevier; 2011.
    1. Hugot J.-P., Laurent-Puig P., Gower-Rousseau C., et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature. 1996;379(6568):821–823. doi: 10.1038/379821a0. - DOI - PubMed

MeSH terms

Substances